Oncomine Myelodysplastic Syndrome MDS Panel Test
Introduction to the Test
The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a state-of-the-art molecular diagnostic test that plays a critical role in the early detection and management of myelodysplastic syndromes and related leukemias. By identifying specific genetic mutations, this test aids healthcare providers in tailoring personalized treatment plans, ultimately improving patient outcomes.
What the Test Measures
This advanced test utilizes next-generation sequencing (NGS) technology to analyze a comprehensive set of genes associated with myelodysplastic syndromes, including:
- ASXL1
- BCOR
- CBL
- CEBPA
- DNMT3A
- EZH2
- ETV6
- FLT3
- GATA2
- HRAS
- IDH1
- IDH2
- IKZF1
- JAK2
- KIT
- KRAS
- MECOM
- MYC
- MPL
- NRAS
- NF1
- NPM1
- PHF6
- PPRF8
- PTPN11
- RUNX1
- SF3B1
- SRSF2
- SMC1A
- SH2B3
- STAG2
- TP53
- TET2
- U2AF1
- WT1
- ZRSR2
- FUSION GENES: ETV6, JAK2, KMT2A, MLL, MECOM, RARA, RUNX1
Who Should Consider This Test?
This test is particularly recommended for individuals exhibiting symptoms or risk factors associated with blood disorders, including:
- Unexplained anemia
- Frequent infections
- Easy bruising or bleeding
- Fatigue
- Family history of myelodysplastic syndromes or leukemia
Benefits of Taking the Test
By undergoing the Oncomine MDS Panel Test, patients can expect:
- Accurate diagnosis of myelodysplastic syndromes and associated leukemias
- Personalized treatment plans based on genetic findings
- Improved monitoring of disease progression
- Access to targeted therapies that may enhance treatment efficacy
Understanding Your Results
Results from the Oncomine MDS Panel Test can provide crucial insights into the genetic landscape of the disease. A hematologist or oncologist will interpret the results, guiding further treatment decisions. It is essential for patients to discuss their results thoroughly with their healthcare provider to understand the implications for their health.
Test Name and Price
Test Name | Discount Price | Regular Price |
---|---|---|
Oncomine Myelodysplastic Syndrome MDS Panel Test | 81900 KSh | 91000 KSh |
Convenient Access Across Kenya
We have branches in all major cities in Kenya, providing easy access to the Oncomine MDS Panel Test. Additionally, we offer home sample collection services for your convenience. To book your test, please call or WhatsApp us at +254711564616.